Countries North America
Celaid Therapeutics Raises $2.6M to Advance CLD-001 Towards US Clinical Trials
Shionogi & Co., Ltd. and Teikoku Ventures, Inc. Join the Round to Accelerate U.S. Clinical Trial Preparations for CLD-001 Celaid Therapeutics Inc...
October 06, 2026 | News
FDA Expands Lilly’s Jaypirca Approval to First-Line CLL/SLL Treatment
Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has approved an additional indication for Jaypirca (pirto...
October 06, 2026 | News
Genmab’s Rina-S Shows Durable Response in Platinum-Resistant Ovarian Cancer
Treatment with Rina-S® 120 mg/m² every three weeks demonstrated a clinically meaningful objective response rate (ORR) and durable median durat...
October 06, 2026 | News
CJ CheilJedang, ADM Form Amino Acid JV to Strengthen Supply in Americas
Proposed joint venture will manufacture and market amino acids critical to the livestock industry, supporting U.S. production, strengthening the global...
October 05, 2026 | News
Lonza and Asimov Partner to Advance Lentiviral Vector Manufacturing for In Vivo Therapies
Collaboration connects Asimov’s genetic design and cell line technologies with Lonza’s process development, scale-up and GMP manufacturin...
October 05, 2026 | News
Piramal and NP2 Advance Generic Cancer Drug Cyclophosphamide Towards US Manufacturing
Piramal and NP2 are set to complete the drug development phase of the generic cancer drug cyclophosphamide this October. The development and manufacturi...
October 02, 2026 | News
Suvoda Expands Unified Clinical Trial Platform With AI-Powered Capabilities
- Suvoda, a global clinical trial technology company, announced a new release of important advancements since unifying the market-leading Suvoda...
October 02, 2026 | News
Health In Tech Launches AI-Powered HitRix Platform for Large-Group Health Insurance
AI-powered HitRix platform streamlines large-group submissions, multi-market quoting, proposal comparison and placement in one secure environment, thereby ...
October 02, 2026 | News
CAS and Novartis Partner to Build AI-Ready Reaction Data Platform for Drug Discovery
Researchers will gain an integrated synthetic data foundation and an advanced custom search platform to support reaction data discovery and analysis ...
October 01, 2026 | News
Piramal Pharma Invests $5.3M to Expand Drug Substance Manufacturing in Canada
Piramal Pharma Solutions is investing over $5.3 million in its Aurora drug substance facility to upgrade site infrastructure. With its investment throug...
October 01, 2026 | Analysis
Link Cell Therapies Begins Phase I Trial of Logic-Gated CAR-T Therapy for Kidney Cancer
LNK001, an AND-gated CAR-T therapy targeting CAIX and ENPP3, is being evaluated in a Phase 1 study in advanced clear cell renal cell carcinoma at MD ...
September 30, 2026 | News
Hengrui Pharma Inks $2.6B Licensing Deal With Novo Nordisk for Oral GLP-1/GIP Therapy
HRS-1596 is a phase I-ready GLP-1/GIP dual receptor agonist for once-weekly oral dosing Total pot...
September 30, 2026 | News
iRegene Advances Off-the-Shelf Retinal Cell Therapy Into Clinical Trials in US and China
Following its Parkinson's disease program, iRegene advances another off-the-shelf cell therapy into clinical development in the U.S. and China. iReg...
September 30, 2026 | News
Lundbeck Relocates US Headquarters to Greater Boston, Establishes Global Innovation Hub
The new hub in Greater Boston will bring Lundbeck closer to one of the world's leading life sciences ecosystems, strengthening access to science, talent ...
September 28, 2026 | News
Most Read
- Can APAC Biomanufacturing Decarbonise Without Pricing Itself Out?
- The Algorithm on the GMP Floor: AI Promises a Smarter Plant. Regulators Demand the Audit Trail.
- APAC's Peptide-Capacity Gamble
- After the Rush: APAC's mRNA and Vaccine Capacity Hangover
- The Biosimilar Race: Factory to the World — or Stuck in the Copycat Economy?
- The Vein-to-Vein Problem: Can APAC's Cold Chain Carry Advanced Therapies?
- Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck
- Can APAC Build Radioligand Therapy Before the Atoms Decay?
- The Great Biopharma Reset: 50 Developments That Changed Everything in H1 2026
- Beyond the Trial: Can Real-World Evidence Earn Regulatory Trust in APAC?
- Beyond the Obvious Giant: Where APAC's Clinical Trials Go Next
- The Frontier That Won’t Quite Arrive
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
